e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Smoking cessation treatment and e-cigarettes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of psychiatric disorders in patients treated with Varenicline.
N. Fouz Rosón (Barcelona, Spain)
Source:
International Congress 2017 – Smoking cessation treatment and e-cigarettes
Session:
Smoking cessation treatment and e-cigarettes
Session type:
Poster Discussion
Number:
4478
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Fouz Rosón (Barcelona, Spain). Influence of psychiatric disorders in patients treated with Varenicline.. 4478
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Withdrawal symptoms in psychiatric patients treated with varenicline
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008
Prevalence of psychiatric disorders in seriously-ill COPD patients
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Treatment of comorbid insomnia disorder: implications for somatic and mental health
Source: Sleep and Breathing Conference 2021
Year: 2021
Problems of treatment of TB patients suffering from alcohol and drugs addiction
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002
Prevalence of psychiatric disorders in patients undergoing specific challenge tests for the diagnosis of occupational asthma
Source: Annual Congress 2008 - Occupational asthma - agents and management
Year: 2008
Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
DOTS-Plus treatment of MDR-TB patients with psychiatric disorders
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Effectiveness of smoking cessation in patients with psychiatric disease
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012
Treatment of narcolepsy and comorbid conditions
Source: Sleep and Breathing Conference 2021
Year: 2021
Longitudinal impact of depressive disorders on asthma control in adult patients
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017
Incidence of asthma in patients with attention deficit hyperactivity disorder (ADHD)
Source: Annual Congress 2005 - What is new in childhood respiratory epidemiology?
Year: 2005
The effects of anxiety and depression on treatment adherence in COPD patients
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Effects of CPAP treatment on anxiety and depression in patients with OSAS
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Influence of COVID-19 pneumonia on development of mental disorders
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
Role and management of COPD concomitant disorders
Source: Annual Congress 2010 - GOLD Update
Year: 2010
Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome
Source: Eur Respir J 2001; 17: 313-315
Year: 2001
Smoking status and levels of anxiety and depression in hospitalized patients.
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018
Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Psychiatric disorders in COPD patients
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept